The Rationale of Patients with Early-Stage Papillary Thyroid Cancer for Accepting or Rejecting Radioactive Iodine Remnant Ablation

Abstract

ThyroidVol. 23, No. 2 Letters to the EditorThe Rationale of Patients with Early-Stage Papillary Thyroid Cancer for Accepting or Rejecting Radioactive Iodine Remnant AblationAnna M. Sawka, Heather Rilkoff, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Shereen Ezzat, Sylvia L. Asa, Phillip Segal, Catherine Kelly, Afshan Zahedi, Amiram Gafni, and David P. GoldsteinAnna M. SawkaDepartment of Medicine (Division of Endocrinology), University Health Network, Toronto, Canada.Department of Medicine (Division of Endocrinology), University of Toronto, Toronto, Canada.Search for more papers by this author, Heather RilkoffDepartment of Medicine (Division of Endocrinology), University Health Network, Toronto, Canada.Search for more papers by this author, Richard W. TsangDepartment of Radiation Oncology, University Health Network, Toronto, Canada.Department of Radiation Oncology, University of Toronto, Toronto, Canada.Search for more papers by this author, James D. BrierleyDepartment of Radiation Oncology, University Health Network, Toronto, Canada.Department of Radiation Oncology, University of Toronto, Toronto, Canada.Search for more papers by this author, Lorne RotsteinDepartment of Surgery, University Health Network, Toronto, Canada.Department of Surgery, University of Toronto, Toronto, Canada.Search for more papers by this author, Shereen EzzatDepartment of Medicine (Division of Endocrinology), University Health Network, Toronto, Canada.Department of Medicine (Division of Endocrinology), University of Toronto, Toronto, Canada.Search for more papers by this author, Sylvia L. AsaDepartment of Pathology, University Health Network, Toronto, Canada.Department of Pathology, University of Toronto, Toronto, Canada.Search for more papers by this author, Phillip SegalDepartment of Medicine (Division of Endocrinology), University Health Network, Toronto, Canada.Department of Medicine (Division of Endocrinology), University of Toronto, Toronto, Canada.Search for more papers by this author, Catherine KellyDepartment of Medicine (Division of Endocrinology), University of Toronto, Toronto, Canada.Division of Endocrinology, Department of Medicine, Women's College Hospital, Toronto, Canada.Search for more papers by this author, Afshan ZahediDepartment of Medicine (Division of Endocrinology), University of Toronto, Toronto, Canada.Division of Endocrinology, Department of Medicine, Women's College Hospital, Toronto, Canada.Search for more papers by this author, Amiram GafniDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.Search for more papers by this author, and David P. GoldsteinOtolaryngology, University Health Network, Toronto, Canada.Otolaryngology, University of Toronto, Toronto, Canada.Search for more papers by this authorPublished Online:11 Feb 2013https://doi.org/10.1089/thy.2012.0422AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"The Rationale of Patients with Early-Stage Papillary Thyroid Cancer for Accepting or Rejecting Radioactive Iodine Remnant Ablation." , 23(2), pp. 246–247FiguresReferencesRelatedDetailsCited byRadioactive iodine therapy: multiple faces of the same polyhedronArchives of Endocrinology and MetabolismDoctor-patient communication in thyroid conditions: Impact on outcomesThyroid Research and Practice, Vol. 18, No. 2Management of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Carcinoma3 March 2017Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension14 July 2015 | Trials, Vol. 16, No. 1Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow‐up from a decision‐aid randomized trial20 July 2015 | Cancer, Vol. 121, No. 20Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros25 June 2015 | Endocrine, Vol. 50, No. 1Prophylactic Central Compartment Neck Dissection for Papillary Thyroid CancerSurgical Clinics of North America, Vol. 94, No. 3 Volume 23Issue 2Feb 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:Anna M. Sawka, Heather Rilkoff, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Shereen Ezzat, Sylvia L. Asa, Phillip Segal, Catherine Kelly, Afshan Zahedi, Amiram Gafni, and David P. Goldstein.The Rationale of Patients with Early-Stage Papillary Thyroid Cancer for Accepting or Rejecting Radioactive Iodine Remnant Ablation.Thyroid.Feb 2013.246-247.http://doi.org/10.1089/thy.2012.0422Published in Volume: 23 Issue 2: February 11, 2013Online Ahead of Editing: September 25, 2012PDF download